References
- 1. Jemec GB. Clinical Practice. Hidradenitis Suppurativa. N Engl J Med 2012; 366 (2): 158-64.10.1056/NEJMcp1014163
- 2. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35 (2 pt 1): 191-4.10.1016/S0190-9622(96)90321-7
- 3. Canoui-Poitrine F, Revuz JE, Wolkenstein P et al. Clinical characteristics of a series of 302 French patiens with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009; 61 (1): 51-7.10.1016/j.jaad.2009.02.013
- 4. Martorell A, Jfri A, Koster SBL et al. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study. J Eur Acad Dermatol Venereol. 2020; 34(6): 1309-1318.10.1111/jdv.16183
- 5. Pecova K. Acne Conglobata Associated with Hidradenitis Suppurativa, Disorders of Follicular Occlusion (Case Report). Acta Medica Martiniana. 2015; 15(2): 30-34.10.1515/acm-2015-0009
- 6. Kurayev A, Ashkar H, Saraiya A, Gottlieb AB. Hidradenitis Suppurativa: Review of the Pathogenesis and Treatment. J Drugs Dermatol. 2016; 15(8): 1017-22.
- 7. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009; 60(4): 539-61.10.1016/j.jaad.2008.11.911
- 8. Van der Zee HH, de Ruiter L, van den Broecke DG, et al. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for tar geting TNF-α and IL-1β. Br J Dermatol 2011;164:1292-8.10.1111/j.1365-2133.2011.10254.x
- 9. Pascual JC, García-Martínez FJ, Martorell A, et al. Increased total serum IgE levels in moderate-to-severe hidradenitis suppurativa. Br J Dermatol. 2016; 175(5): 1101-1102.10.1111/bjd.14870
- 10. Wittig HJ, Belloit J, De Fillippi I, Royal G. Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease. J Allergy Clin Immunol 1980; 66 (4): 305-13.10.1016/0091-6749(80)90026-3
- 11. Hetman S, Kivity S, Greif J, et al. IgE values in the allergic and healthy Israeli population. Ann Allergy 1988; 61 (2): 123-8.
- 12. Kobayashi N, Nagumo H, Agematsu K. IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction. Clin Exp Immunol 2002; 129 (3): 446-52.10.1046/j.1365-2249.2002.01932.x190646312197885
- 13. Van der Zee HH, de Ruiter L, Boer J, et al. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol 2012; 166 (1): 98-106.10.1111/j.1365-2133.2011.10643.x21929531
- 14. Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011; 65 (4): 790-8.10.1016/j.jaad.2010.07.01021641076